GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Genexine 095700.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

1,988

-2.55%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩4.57bn

FY2016FY2025

Net income

−₩27.22bn

FY2016FY2025

Free cash flow

−₩44.34bn

FY2016FY2025

Shareholders' equity

₩246.76bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩4.57bn₩2.93bn₩4.43bn₩16.14bn₩36.83bn₩18.54bn₩11.30bn₩12.88bn₩28.45bn₩11.35bn
Research and development₩26.62bn₩22.02bn₩26.33bn₩26.44bn₩33.12bn₩39.21bn————
Operating income−₩36.07bn−₩63.84bn−₩64.28bn−₩33.68bn−₩19.10bn−₩39.15bn−₩44.54bn−₩38.15bn−₩26.89bn−₩30.91bn
Net income−₩27.22bn−₩63.71bn−₩66.87bn−₩56.27bn−₩47.73bn₩27.57bn−₩16.51bn−₩34.07bn−₩19.33bn−₩30.93bn
Diluted earnings per share-598.40-1,400.76-1,613.36-1,721.54-1,382.801,116.28-694.79-1,209.39-698.54-1,260.91

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩371.27bn₩345.04bn₩376.59bn₩388.78bn₩636.86bn₩596.91bn₩358.18bn₩374.81bn₩140.73bn₩198.71bn
Cash and short-term investments—₩32.08bn₩64.48bn₩21.94bn₩27.80bn₩6.71bn₩82.52bn₩171.00bn₩10.43bn₩59.28bn
Total liabilities₩124.51bn₩83.36bn₩79.68bn₩112.63bn₩119.12bn₩61.30bn₩61.27bn₩54.30bn₩26.83bn₩28.47bn
Debt₩6.56bn₩75.71bn₩67.43bn₩84.08bn₩52.22bn₩27.16bn₩39.38bn₩34.61bn₩15.29bn₩20.01bn
Shareholders' equity₩246.76bn₩261.68bn₩296.62bn₩276.15bn₩517.74bn₩535.61bn₩296.91bn₩320.51bn₩113.91bn₩170.24bn
Shares outstanding45m45m41m33m35m25m24m28m28m25m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−₩29.58bn−₩1.65bn−₩38.05bn−₩39.80bn−₩12.75bn−₩22.69bn−₩41.57bn−₩20.05bn−₩26.10bn−₩14.10bn
Capital spending−₩14.76bn−₩7.30bn−₩7.38bn−₩31.75bn−₩56.43bn−₩22.21bn−₩3.96bn−₩8.01bn−₩20.51bn−₩5.07bn
Free cash flow−₩44.34bn−₩8.95bn−₩45.43bn−₩71.55bn−₩69.18bn−₩44.90bn−₩45.53bn−₩28.06bn−₩46.61bn−₩19.16bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩972.2m₩414.7m₩537.0m₩3.05bn₩671.9m₩319.5m₩305.8m₩209.2m
Operating income—−₩9.00bn−₩13.99bn—−₩7.50bn−₩8.48bn−₩7.36bn−₩14.06bn
Net income−₩26.27bn−₩12.44bn−₩14.64bn₩21.05bn−₩14.70bn−₩18.92bn−₩25.51bn−₩14.54bn
Diluted earnings per share-577.57-273.62-321.91462.89-323.29-416.10-560.89-350.80
Cash from operations−₩10.93bn−₩3.07bn−₩11.15bn−₩2.97bn−₩8.81bn₩799.0m−₩1.65bn−₩12.20bn
Capital spending—−₩5.28bn−₩2.38bn−₩5.08bn−₩3.41bn−₩3.89bn−₩7.30bn−₩5.32bn
Free cash flow—−₩8.34bn−₩13.53bn−₩8.05bn−₩12.22bn−₩3.09bn−₩8.95bn−₩17.52bn
Total assets₩331.75bn₩355.17bn₩371.27bn₩366.23bn₩332.69bn₩337.55bn₩345.04bn₩341.00bn
Cash and short-term investments—————₩30.60bn₩32.08bn₩39.76bn
Debt₩4.59bn₩5.57bn₩6.56bn₩37.26bn₩34.38bn₩84.66bn₩75.64bn₩72.31bn
Shareholders' equity₩200.12bn₩229.66bn₩246.76bn₩260.01bn₩234.17bn₩242.83bn₩261.68bn₩258.76bn

Financial ratios

Data as of 5 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-788.7%-2176.7%-1452.1%-208.7%-51.9%-211.1%
Net margin-595.0%-2172.2%-1510.7%-348.7%-129.6%148.7%
Return on equity-11.0%-24.3%-22.5%-20.4%-9.2%5.1%
Return on assets-7.3%-18.5%-17.8%-14.5%-7.5%4.6%
Revenue growth56.0%-33.7%-72.6%-56.2%98.6%64.1%
Earnings growth-57.3%-4.7%18.8%17.9%-273.1%-267.0%
Current ratio0.39x0.87x1.69x0.66x0.74x0.51x
Debt to equity0.03x0.29x0.23x0.25x0.10x0.05x
Equity ratio66.5%75.8%78.8%71.0%81.3%89.7%
Interest coverage-14.76x-24.14x-15.64x-10.19x-38.79x-13.40x
R&D as a share of sales581.9%751.0%594.8%163.9%89.9%211.4%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-34.3%-24.4%-17.8%
Operating income2.3%-1.6%81.2%
Net income-21.5%—34.3%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-1331.0%-704.9%-306.9%-220.4%
Net margin-1211.2%-762.6%-280.7%-187.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-7.8-3.8-6.1-8.4-30.380.0-64.6-43.1-75.1-24.6
Price to sales46.682.892.729.139.3118.994.4114.151.067.0

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 13-for-10 split · 11 Jan 2023
  • 939-for-877 split · 9 Nov 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.